← back to search

Fei Xue

Qingdao University of Science and Technology · CN
Area of research
Psychiatry and Mental health · Oncology
Research interest
Research interests include Migraine and Headache Studies, Cancer Risks and Factors, Birth, Development, and Health, and Neurological Complications and Syndromes.
h-index
30
citations
3,517
works
133
NIH funding
primary concept
Medicine
email

Recent publications

Associations of different insulin resistance-related indices with the incidence and progression trajectory of cardiometabolic multimorbidity: a prospective cohort study from UK biobank
Cardiovascular Diabetology 2025cited by 42position: lastdoi
Comparison of proximal gastrectomy with tubular esophagogastric anastomosis and total gastrectomy with Roux-en-Y reconstruction in the treatment of adenocarcinoma of the esophagogastric junction of Siewert type II/III at stage II
BMC Surgery 2024cited by 2position: middledoi
Cardiomyocyte-specific knockout of ADAM17 ameliorates left ventricular remodeling and function in diabetic cardiomyopathy of mice
Signal Transduction and Targeted Therapy 2022cited by 118position: firstdoi
MicroRNA‑141 inhibits the differentiation of bone marrow‑derived mesenchymal stem cells in steroid‑induced osteonecrosis via E2F3
Molecular Medicine Reports 2022cited by 8position: firstdoi
Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial
European Journal of Neurology 2021cited by 176position: middledoi
The E3 ubiquitin ligase TRIM31 plays a critical role in hypertensive nephropathy by promoting proteasomal degradation of MAP3K7 in the TGF-β1 signaling pathway
Cell Death and Differentiation 2021cited by 63position: middledoi
Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura
JAMA Neurology 2021cited by 41position: middledoi
Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine
Cephalalgia 2019cited by 100position: middledoi
Bladder drug mirabegron exacerbates atherosclerosis through activation of brown fat-mediated lipolysis
Proceedings of the National Academy of Sciences 2019cited by 79position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yun Zhang · Qingdao University3 papers (2019–2022)Peter J. Goadsby · King Abdullah University of Science and Technology3 papers (2019–2021)Messoud Ashina · Knowledge Centre for Agriculture3 papers (2019–2021)Wenhai Sui · Shandong University3 papers (2019–2022)David W. Dodick · New York Academy of Medicine3 papers (2019–2021)Cheng Cheng · Shandong University2 papers (2021–2022)Cheng Zhang · Shanghai Sixth People's Hospital2 papers (2019–2022)Stephen D. Silberstein · Thomas Jefferson University2 papers (2019–2021)Daniel D. Mikol · Amgen (United States)2 papers (2019–2021)Gabriel Paiva da Silva Lima · Amgen (United States)2 papers (2021–2021)Sunfa Cheng · Amgen (United States)2 papers (2019–2021)Uwe Reuter · Universitätsmedizin Greifswald2 papers (2019–2021)Hongshi Li · Nankai University1 papers (2019–2019)Qian Li · Yangzhou University1 papers (2021–2021)Wenbo Wang · Harbin Medical University1 papers (2022–2022)Yan Liu · Nanjing University of the Arts1 papers (2022–2022)Yifei Li · Xi'an Jiaotong University1 papers (2025–2025)Na Li · Guizhou Normal University1 papers (2021–2021)Yuan Liu · Shanghai Jiao Tong University1 papers (2022–2022)Han Zhang · Aviation Industry Corporation of China (China)1 papers (2019–2019)